Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment

CONCLUSIONS: Anti-IL-8 monoclonal antibody exhibits promising immunotherapeutic properties through targeting both autophagy and CSCs maintenance within breast cancer TME.PMID:38552109 | PMC:PMC10977415 | DOI:10.3233/BD-230052

Source: Breast Disease - March 29, 2024 Category: Cancer & Oncology Authors: Seham Abou Shousha Eman Medhat Suzan Baheeg Yasmine Shahine Source Type: research